Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.

Identifieur interne : 003C42 ( Main/Exploration ); précédent : 003C41; suivant : 003C43

Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.

Auteurs : RBID : pubmed:10392379

English descriptors

Abstract

The localization of carcinoids in the gastrointestinal tract is frequently difficult if not impossible with the imaging procedures used to date. It is reported on a patient with metastasizing carcinoid in whom various imaging procedures were not successful in detecting the primary tumor. Due to the importance of primary tumor proof for potential curative surgical therapy, a whole-body positron emission tomography with F-18-DOPA was performed. PET enabled localization of a potential primary tumor in the ileum. Moreover, in addition to the known abdominal lymph node and liver metastases, it detected a mediastinal lymph node metastasis and a pulmonary metastasis. F-18-DOPA whole-body PET may be a very promising imaging approach to the localization and staging of gastrointestinal carcinoids.

PubMed: 10392379

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.</title>
<author>
<name sortKey="Hoegerle, S" uniqKey="Hoegerle S">S Hoegerle</name>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Nuclear Medicine, Albert Ludwigs University, School of Medicine, Freiburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Division of Nuclear Medicine, Albert Ludwigs University, School of Medicine, Freiburg</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Fribourg-en-Brisgau</region>
<settlement type="city">Fribourg-en-Brisgau</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schneider, B" uniqKey="Schneider B">B Schneider</name>
</author>
<author>
<name sortKey="Kraft, A" uniqKey="Kraft A">A Kraft</name>
</author>
<author>
<name sortKey="Moser, E" uniqKey="Moser E">E Moser</name>
</author>
<author>
<name sortKey="Nitzsche, E U" uniqKey="Nitzsche E">E U Nitzsche</name>
</author>
</titleStmt>
<publicationStmt>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10392379</idno>
<idno type="pmid">10392379</idno>
<idno type="wicri:Area/Main/Corpus">003E59</idno>
<idno type="wicri:Area/Main/Curation">003E59</idno>
<idno type="wicri:Area/Main/Exploration">003C42</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Carcinoid Tumor (pathology)</term>
<term>Carcinoid Tumor (radionuclide imaging)</term>
<term>Dihydroxyphenylalanine (analogs & derivatives)</term>
<term>Dihydroxyphenylalanine (diagnostic use)</term>
<term>Dihydroxyphenylalanine (pharmacokinetics)</term>
<term>Fluorine Radioisotopes (diagnostic use)</term>
<term>Fluorine Radioisotopes (pharmacokinetics)</term>
<term>Gastrointestinal Neoplasms (radionuclide imaging)</term>
<term>Humans</term>
<term>Indium Radioisotopes (diagnostic use)</term>
<term>Liver Neoplasms (radionuclide imaging)</term>
<term>Liver Neoplasms (secondary)</term>
<term>Lung Neoplasms (radionuclide imaging)</term>
<term>Lung Neoplasms (secondary)</term>
<term>Lymphatic Metastasis (radionuclide imaging)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Receptors, Somatostatin (analysis)</term>
<term>Somatostatin (analogs & derivatives)</term>
<term>Somatostatin (diagnostic use)</term>
<term>Tissue Distribution</term>
<term>Tomography, Emission-Computed</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Dihydroxyphenylalanine</term>
<term>Somatostatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Receptors, Somatostatin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en">
<term>Dihydroxyphenylalanine</term>
<term>Fluorine Radioisotopes</term>
<term>Indium Radioisotopes</term>
<term>Somatostatin</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Carcinoid Tumor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en">
<term>Dihydroxyphenylalanine</term>
<term>Fluorine Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en">
<term>Carcinoid Tumor</term>
<term>Gastrointestinal Neoplasms</term>
<term>Liver Neoplasms</term>
<term>Lung Neoplasms</term>
<term>Lymphatic Metastasis</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en">
<term>Liver Neoplasms</term>
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Tissue Distribution</term>
<term>Tomography, Emission-Computed</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The localization of carcinoids in the gastrointestinal tract is frequently difficult if not impossible with the imaging procedures used to date. It is reported on a patient with metastasizing carcinoid in whom various imaging procedures were not successful in detecting the primary tumor. Due to the importance of primary tumor proof for potential curative surgical therapy, a whole-body positron emission tomography with F-18-DOPA was performed. PET enabled localization of a potential primary tumor in the ileum. Moreover, in addition to the known abdominal lymph node and liver metastases, it detected a mediastinal lymph node metastasis and a pulmonary metastasis. F-18-DOPA whole-body PET may be a very promising imaging approach to the localization and staging of gastrointestinal carcinoids.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">10392379</PMID>
<DateCreated>
<Year>1999</Year>
<Month>07</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1999</Year>
<Month>07</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2012</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0029-5566</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>38</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1999</Year>
</PubDate>
</JournalIssue>
<Title>Nuklearmedizin. Nuclear medicine</Title>
<ISOAbbreviation>Nuklearmedizin</ISOAbbreviation>
</Journal>
<ArticleTitle>Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.</ArticleTitle>
<Pagination>
<MedlinePgn>127-30</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The localization of carcinoids in the gastrointestinal tract is frequently difficult if not impossible with the imaging procedures used to date. It is reported on a patient with metastasizing carcinoid in whom various imaging procedures were not successful in detecting the primary tumor. Due to the importance of primary tumor proof for potential curative surgical therapy, a whole-body positron emission tomography with F-18-DOPA was performed. PET enabled localization of a potential primary tumor in the ileum. Moreover, in addition to the known abdominal lymph node and liver metastases, it detected a mediastinal lymph node metastasis and a pulmonary metastasis. F-18-DOPA whole-body PET may be a very promising imaging approach to the localization and staging of gastrointestinal carcinoids.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hoegerle</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<Affiliation>Division of Nuclear Medicine, Albert Ludwigs University, School of Medicine, Freiburg, Germany.</Affiliation>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kraft</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Moser</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nitzsche</LastName>
<ForeName>E U</ForeName>
<Initials>EU</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY</Country>
<MedlineTA>Nuklearmedizin</MedlineTA>
<NlmUniqueID>7609387</NlmUniqueID>
<ISSNLinking>0029-5566</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Fluorine Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Indium Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Somatostatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>138661-02-6</RegistryNumber>
<NameOfSubstance>pentetreotide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2C598205QX</RegistryNumber>
<NameOfSubstance>fluorodopa F 18</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51110-01-1</RegistryNumber>
<NameOfSubstance>Somatostatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63-84-3</RegistryNumber>
<NameOfSubstance>Dihydroxyphenylalanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carcinoid Tumor</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
<QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dihydroxyphenylalanine</DescriptorName>
<QualifierName MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fluorine Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gastrointestinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">radionuclide imaging</QualifierName>
<QualifierName MajorTopicYN="Y">secondary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
<QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Somatostatin</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Somatostatin</DescriptorName>
<QualifierName MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Tomography, Emission-Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1999</Year>
<Month>7</Month>
<Day>7</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1999</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1999</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">10392379</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C42 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C42 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:10392379
   |texte=   Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:10392379" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a IndiumV2 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024